From: Extrahepatic metastases of hepatocellular carcinoma on 18F FDG PET CT
Lymphnodal involvement | n(%) | Size range (cm) | FDG + ve | FDG-ve | SUVmax range (gm/ml) | Necrotic | Non-necrotic |
---|---|---|---|---|---|---|---|
Lower cervical | 3(5.3%) | 0.9 cm–1.5 cm | 3 (5.3%) | 0 (0%) | 1.8–7.5 | 0(0%) | 3(5.3%) |
Subcarinal | 3(5.3%) | 1.3 cm–4.8 cm | 3(5.3%) | 0(0%) | 2.5–16.8 | 0(0%) | 3(5.3%) |
Paratracheal | 7(12.5%) | < 1.2 cm–2.5 cm | 6 (10.7%) | 1 (1.7 %) | 2.5–8.6 | 1(1.7%) | 7 (12.5%)* |
Hilar | 3(5.3%) | 1.1 cm–1.7 cm | 2 (3.5%) | 1(1.7 %) | 2.9–8 | 0(0%) | 3(5.3%) |
Interlobar | 1(1.7%) | 0.9 cm | 1(1.7%) | 0(0%) | 3.3 | 0(0%) | 1(1.7%) |
Paracardiac | 1(1.7%) | 0.7 cm | 0(0%) | 1(1.7 %) | - | 0(0%) | 1(1.7%) |
Juxtaphrenic | 5(8.9%) | 1.1 cm–2 cm | 3(5.3%) | 2(3.5 %) | 2.1–3.5 | 0(0%) | 5 (8.9%) |
Mesenteric | 4(7.1%) | < 1 cm–1.9 cm | 1(1.7%) | 3(5.3 %) | 5.4 | 0(0%) | 4 (7.1%) |
Iliac | 1(1.7%) | < 1 cm | 1(1.7%) | 0(0%) | 4.2 | 0(0%) | 1(1.7%) |
Interlobar | 2(3.5%) | 1.1 cm–1.6 cm | 2(3.5%) | 0(0%) | 3.3–4.9 | 1(1.7%) | 1(1.7%) |
Common iliac | 3(5.3%) | 1.5 cm–2 cm | 3(5.3%) | 0(0%) | 6.6–9.5 | 0(0%) | 3(5.3%) |